マーケットレポート詳細
細胞培養用培地の世界市場：培地タイプ別、用途別2028年予測
Cell Culture Media Market by Type (Serum-free (CHO, BHK, Vero Cell), Stem Cell, Chemically Defined, Classical, Specialty), Application (Biopharmaceutical (mAbs, Vaccine), Diagnostics, Tissue Engineering), End User (Pharma, Biotech) & Region - Global Forecast to 2028
- 出版元：MarketsandMarkets
出版元について - 発行年：2023年7月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文316ページになります。
- 商品コード：MAM3347
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
細胞培養用培地の世界市場規模は2023年の62億ドルから、2028年までに130億ドルへと急成長し、予測期間の市場の平均年成長率は16.0%で推移することが見込まれています。
レポートは細胞培養用培地の世界市場について2028年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（タイプ別市場、用途別市場、等）を中心に構成されています。また競合状況、主要企業情報（12社）、市場ダイナミクス、特許分析などの分析も加味し、細胞培養用培地市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆細胞培養用培地の世界市場予測2021-2028年
・市場規模(US$)
◆タイプ別、市場-2028年
無血清培地
・CHO
・HEK 293
・BHK
・ベロ細胞
・幹細胞
・免疫細胞
・昆虫細胞
・その他無血清培地
クラシカル培地/塩
幹細胞培養用培地
CD培地
特殊培地
その他細胞培養用培地
※(市場規模US$)
◆用途別、市場-2028年
バイオ医薬品製造
・モノクローナル抗体産生
・ワクチン製造
・その他治療用タンパク質生成
診断
組織工学/再生医療
・細胞/遺伝子治療
・その他組織工学/再生医療
薬剤スクリーニング/開発
その他用途
※(市場規模US$)
◆エンドユーザー別、市場-2028年
・製薬/バイオテクノロジー企業
・病院/診断研究所
・研究/学術機関
・その他エンドユーザー
※(市場規模US$)
◆主要国地域別市場-2028年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド、韓国
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス（促進要因、障壁、機会、課題）
・特許分析
・バリューチェーン分析
・サプライチェーン分析
・エコシステム分析
・価格分析
・貿易分析
・業界構造分析（ファイブフォース分析）
・主要なステークホルダーと購買基準
・競合状況
・市場シェア分析
◆細胞培養用培地の主要企業プロフィール動向
・THERMO FISHER SCIENTIFIC INC.
・MERCK KGAA
・DANAHER
・SARTORIUS AG
・CORNING INCORPORATED
・富士フィルムホールディングス株式会社
・LONZA
・BECTON, DICKINSON AND COMPANY (BD)
・STEMCELL TECHNOLOGIES
・MILTENYI BIOTEC
・HIMEDIA LABORATORIES
・BIOLOGOS
（その他企業）
・CELL APPLICATIONS, INC.
・CAISSON LABS INC.
・PROMOCELL GMBH
・CELL BIOLOGICS, INC.
・INVIVOGEN
・PAN-BIOTECH
・CELLULAR TECHNOLOGY LIMITED
・ZENBIO, INC.
・ATHENA ENVIRONMENTAL SCIENCES, INC.
・CYAGEN BIOSCIENCES
・BIOWEST
・AKRON BIOTECH.
・KCELL BIOSCIENCES
・WELGENE INC.
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS 30
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 1 CELL CULTURE MEDIA MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY RESEARCH 34
・ FIGURE 2 BREAKDOWN OF PRIMARIES: CELL CULTURE MEDIA MARKET
2.2 MARKET ESTIMATION METHODOLOGY
・ FIGURE 3 CELL CULTURE MEDIA MARKET SIZE ESTIMATION, 2022
・ FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1—COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2022
・ FIGURE 5 ILLUSTRATIVE EXAMPLE OF MERCK KGAA: REVENUE SHARE ANALYSIS (2022)
・ FIGURE 6 KEY INDUSTRY INSIGHTS
2.3 MARKET GROWTH RATE PROJECTIONS
・ FIGURE 7 CELL CULTURE MEDIA MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
・ FIGURE 8 CELL CULTURE MEDIA MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
・ FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT
・ TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2022–2028 (% GROWTH)
・ TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
・ TABLE 3 US HEALTH EXPENDITURE, 2023–2030 (USD MILLION)
3 EXECUTIVE SUMMARY
・ FIGURE 10 CELL CULTURE MEDIA MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
・ FIGURE 11 CELL CULTURE MEDIA MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
・ FIGURE 12 CELL CULTURE MEDIA MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
・ FIGURE 13 CELL CULTURE MEDIA MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 CELL CULTURE MEDIA MARKET OVERVIEW
・ FIGURE 14 RISING R&D SPENDING IN PHARMA COMPANIES AND EMERGING CELL CULTURE TECHNOLOGIES FOR CELL-BASED VACCINES TO DRIVE MARKET
4.2 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE AND COUNTRY (2022)
・ FIGURE 15 SERUM-FREE MEDIA SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN CELL CULTURE MEDIA MARKET IN 2022
4.3 CELL CULTURE MEDIA MARKET SHARE, BY APPLICATION, 2023 VS. 2028
・ FIGURE 16 BIOPHARMACEUTICAL PRODUCTION SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028
4.4 CELL CULTURE MEDIA MARKET, BY END USER, 2022 (USD MILLION)
・ FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED MARKET IN 2022
4.5 CELL CULTURE MEDIA MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 19 CELL CULTURE MEDIA MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
・ TABLE 4 CELL CULTURE MEDIA MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 EMERGING CELL CULTURE TECHNOLOGIES FOR CELL-BASED VACCINES
・ TABLE 5 APPROVED CELL CULTURE-BASED VACCINES FOR INFLUENZA
5.2.1.2 INCREASING DEMAND FOR MONOCLONAL ANTIBODIES AND BIOSIMILARS
・ TABLE 6 APPROVED MONOCLONAL ANTIBODIES BY US FDA FOR THERAPEUTIC USE
5.2.1.3 LAUNCH OF NEW CELL CULTURE MEDIA PRODUCTS BY MARKET PLAYERS
5.2.1.4 RISING R&D INVESTMENTS BY PHARMACEUTICAL COMPANIES
・ FIGURE 20 GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028
5.2.1.5 INCREASING DEMAND FOR SERUM- AND ANIMAL COMPONENT-FREE MEDIA
5.2.1.6 GROWTH IN STEM CELL RESEARCH
5.2.1.7 GROWING FOCUS ON PERSONALIZED MEDICINE
・ TABLE 7 GROWTH IN NUMBER OF PERSONALIZED MEDICATIONS, 2015–2022
5.2.2 RESTRAINTS
5.2.2.1 EXPENSIVE CELL BIOLOGY RESEARCH PRODUCTS
5.2.2.2 ETHICAL CONCERNS REGARDING CELL BIOLOGY RESEARCH
5.2.3 OPPORTUNITIES
5.2.3.1 ADVANCEMENTS IN 3D CELL CULTURE
5.2.3.2 INCREASING INCIDENCE OF INFECTIOUS DISEASES AND OUTBREAKS OF PANDEMICS
・ TABLE 8 PROJECTED INCREASE IN COUNT OF CANCER PATIENTS, 2015 VS. 2018 VS. 2020 VS. 2035
・ TABLE 9 ESTIMATED COUNT OF NEW CASES OF CANCER, EXCLUDING NON-MELANOMA SKIN CANCER, AGE (0–85+), 2020–2040
5.2.3.3 EMERGING MARKETS
5.2.4 CHALLENGES
5.2.4.1 SURVIVAL OF SMALL PLAYERS AND NEW ENTRANTS
5.3 IMPACT OF UNCERTAINTIES ON CELL CULTURE MEDIA MARKET
・ FIGURE 21 CELL CULTURE MEDIA MARKET: SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
・ FIGURE 22 REVENUE SHIFT & NEW REVENUE POCKETS FOR CELL CULTURE MEDIA PROVIDERS
5.5 PATENT ANALYSIS
・ FIGURE 23 CELL CULTURE MEDIA MARKET: PATENT APPLICATIONS, JANUARY 2012–JUNE 2023
・ TABLE 10 CELL CULTURE MEDIA MARKET: INDICATIVE LIST OF PATENTS
5.6 VALUE CHAIN ANALYSIS
・ FIGURE 24 VALUE CHAIN ANALYSIS OF CELL CULTURE MEDIA MARKET: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
5.7 SUPPLY CHAIN ANALYSIS
・ FIGURE 25 CELL CULTURE MEDIA MARKET: SUPPLY CHAIN ANALYSIS
5.8 CELL CULTURE MEDIA MARKET: ECOSYSTEM ANALYSIS
・ TABLE 11 CELL CULTURE MEDIA MARKET: ECOSYSTEM
5.9 KEY CONFERENCES AND EVENTS, 2023–2024
・ TABLE 12 CELL CULTURE MEDIA MARKET: CONFERENCES AND EVENTS
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE TRENDS OF DIFFERENT TYPES OF MEDIA/1000L IN DEVELOPED AND DEVELOPING REGIONS (2022)
・ TABLE 13 AVERAGE SELLING PRICE OF DIFFERENT TYPES OF MEDIA (2022)
5.11 TRADE ANALYSIS (HS CODES)
・ TABLE 14 EXPORT DATA FOR PREPARED CULTURE MEDIA, BY COUNTRY, 2018–2022 (USD THOUSAND)
・ TABLE 15 IMPORT DATA FOR PREPARED CULTURE MEDIA, BY COUNTRY, 2018–2022 (USD THOUSAND)
5.12 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 16 CELL CULTURE MEDIA MARKET: PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.13 REGULATORY ANALYSIS
5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
・ FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF CELL CULTURE MEDIA PRODUCTS
5.14.2 BUYING CRITERIA FOR CELL CULTURE MEDIA
・ FIGURE 27 KEY BUYING CRITERIA FOR END USERS
6 CELL CULTURE MEDIA MARKET, BY TYPE
6.1 INTRODUCTION
・ TABLE 17 CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
6.1.1 SERUM-FREE MEDIA 79
・ TABLE 18 SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS
・ TABLE 19 SERUM-FREE MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 20 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 21 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 22 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 23 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 24 SERUM-FREE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
6.1.1.1 CHO MEDIA
6.1.1.1.1 GROWING ADOPTION OF CHO MEDIA IN BIOPHARMACEUTICAL COMPANIES TO DRIVE MARKET
・ TABLE 25 CHO MEDIA OFFERED BY KEY MARKET PLAYERS
・ TABLE 26 CHO MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 27 NORTH AMERICA: CHO MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 28 EUROPE: CHO MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 29 ASIA PACIFIC: CHO MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 30 LATIN AMERICA: CHO MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.1.1.2 HEK 293 MEDIA
6.1.1.2.1 ADVANTAGES OF HEK 293 CELL LINES TO BOOST MARKET
・ TABLE 31 HEK 293 MEDIA OFFERED BY KEY MARKET PLAYERS
・ TABLE 32 HEK 293 MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 33 NORTH AMERICA: HEK 293 MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 34 EUROPE: HEK 293 MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 35 ASIA PACIFIC: HEK 293 MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 36 LATIN AMERICA: HEK 293 MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.1.1.3 BHK MEDIA
6.1.1.3.1 WIDE APPLICATIONS OF BHK MEDIA IN PRODUCTION OF RECOMBINANT PROTEINS TO BOLSTER MARKET
・ TABLE 37 BHK MEDIA OFFERED BY KEY MARKET PLAYERS
・ TABLE 38 BHK MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 39 NORTH AMERICA: BHK MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 40 EUROPE: BHK MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 41 ASIA PACIFIC: BHK MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 42 LATIN AMERICA: BHK MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.1.1.4 VERO CELL MEDIA
6.1.1.4.1 INCREASING ROLE OF VERO CELLS IN RESEARCH PERTAINING TO VIRAL VACCINES TO BOOST MARKET
・ TABLE 43 VERO CELL MEDIA OFFERED BY KEY MARKET PLAYERS
・ TABLE 44 VERO CELL MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 45 NORTH AMERICA: VERO CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 46 EUROPE: VERO CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 47 ASIA PACIFIC: VERO CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 48 LATIN AMERICA: VERO CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.1.1.5 SERUM-FREE STEM CELL MEDIA
6.1.1.5.1 AVAILABILITY OF FUNDING FOR STEM CELL RESEARCH TO PROPEL MARKET
・ TABLE 49 SERUM-FREE STEM CELL MEDIA OFFERED BY KEY MARKET PLAYERS
・ TABLE 50 SERUM-FREE STEM CELL MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 51 NORTH AMERICA: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 52 EUROPE: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 53 ASIA PACIFIC: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 54 LATIN AMERICA: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.1.1.6 IMMUNE CELL MEDIA
6.1.1.6.1 GROWING DEMAND FOR RESEARCH ON IMMUNE CELLS TO FUEL MARKET
・ TABLE 55 IMMUNE CELL MEDIA OFFERED BY KEY MARKET PLAYERS
・ TABLE 56 IMMUNE CELL MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 57 NORTH AMERICA: IMMUNE CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 58 EUROPE: IMMUNE CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 59 ASIA PACIFIC: IMMUNE CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 60 LATIN AMERICA: IMMUNE CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.1.1.7 INSECT CELL MEDIA
6.1.1.7.1 GROWING ADOPTION OF INSECT CELL MEDIA FOR HETEROLOGOUS PROTEIN EXPRESSION TO DRIVE MARKET
・ TABLE 61 INSECT CELL MEDIA OFFERED BY KEY MARKET PLAYERS
・ TABLE 62 INSECT CELL MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 63 NORTH AMERICA: INSECT CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 64 EUROPE: INSECT CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 65 ASIA PACIFIC: INSECT CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 66 LATIN AMERICA: INSECT CELL MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.1.1.8 OTHER SERUM-FREE MEDIA
・ TABLE 67 OTHER SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS
・ TABLE 68 OTHER SERUM-FREE MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 69 NORTH AMERICA: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 70 EUROPE: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 71 ASIA PACIFIC: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 72 LATIN AMERICA: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.1.2 CLASSICAL MEDIA & SALTS
6.1.2.1 WIDE USE OF CLASSICAL MEDIA & SALTS ACROSS ALL TYPES OF CELL CULTURE APPLICATIONS TO BOOST MARKET
・ TABLE 73 CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS
・ TABLE 74 CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 75 NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 76 EUROPE: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 77 ASIA PACIFIC: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 78 LATIN AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.1.3 STEM CELL CULTURE MEDIA
6.1.3.1 INCREASING COLLABORATIONS FOR STEM CELL RESEARCH TO BOLSTER MARKET 107
・ TABLE 79 STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS
・ TABLE 80 STEM CELL CULTURE MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 81 NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 82 EUROPE: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 83 ASIA PACIFIC: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 84 LATIN AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.1.4 CHEMICALLY DEFINED (CD) MEDIA
6.1.4.1 ABILITY OF CD MEDIA TO INCREASE REPRODUCIBILITY TO DRIVE MARKET
・ TABLE 85 CHEMICALLY DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS
・ TABLE 86 CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 87 NORTH AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 88 EUROPE: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 89 ASIA PACIFIC: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 90 LATIN AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.1.5 SPECIALTY MEDIA 113
6.1.5.1 ABILITY OF PRIMARY CELLS TO PROLIFERATE IN SPECIALTY MEDIA TO FUEL MARKET
・ TABLE 91 SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS
・ TABLE 92 SPECIALTY MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 93 NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 94 EUROPE: SPECIALTY MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 95 ASIA PACIFIC: SPECIALTY MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 96 LATIN AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.1.6 OTHER CELL CULTURE MEDIA
・ TABLE 97 OTHER CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS
・ TABLE 98 OTHER CELL CULTURE MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 99 NORTH AMERICA: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 100 EUROPE: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 101 ASIA PACIFIC: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 102 LATIN AMERICA: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 CELL CULTURE MEDIA MARKET, BY APPLICATION
7.1 INTRODUCTION
・ TABLE 103 CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
7.2 BIOPHARMACEUTICAL PRODUCTION
・ TABLE 104 CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 105 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 106 EUROPE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 107 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 108 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 109 CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
7.2.1 MONOCLONAL ANTIBODY PRODUCTION
7.2.1.1 GROWING DEMAND FOR MONOCLONAL ANTIBODY PRODUCTION TO FUEL MARKET GROWTH
・ TABLE 110 INDICATIVE LIST OF APPROVED ANTIBODY PRODUCTS PRODUCED IN CHO CELLS
・ TABLE 111 INDICATIVE LIST OF MONOCLONAL ANTIBODIES WITH FDA AUTHORIZATION
・ TABLE 112 CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 113 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 114 EUROPE: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 115 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 116 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
7.2.2 VACCINE PRODUCTION
7.2.2.1 GROWING GOVERNMENT SUPPORT FOR VACCINE PRODUCTION TO BOOST MARKET
・ TABLE 117 NIH FUNDING FOR VACCINE RESEARCH, 2020–2024 (USD MILLION)
・ TABLE 118 CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 119 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 120 EUROPE: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 121 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 122 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
7.2.3 OTHER THERAPEUTIC PROTEIN PRODUCTION APPLICATIONS
・ TABLE 123 CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 124 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 125 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 126 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 127 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 DIAGNOSTICS 133
7.3.1 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
・ TABLE 128 CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 129 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 130 EUROPE: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 131 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 132 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE
・ TABLE 133 CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 134 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 135 EUROPE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 136 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 137 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 138 CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
7.4.1 CELL & GENE THERAPY
7.4.1.1 INCREASING ADOPTION OF CELL AND GENE THERAPIES FOR TREATING PATIENTS TO PROPEL MARKET
・ TABLE 139 CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 140 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 141 EUROPE: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 142 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 142
・ TABLE 143 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
7.4.2 OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS
・ TABLE 144 CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 145 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 146 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 147 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 148 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 DRUG SCREENING & DEVELOPMENT
7.5.1 ADOPTION OF CELL-BASED ASSAYS IN DRUG DISCOVERY TO BOOST MARKET
・ TABLE 149 CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 150 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 151 EUROPE: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 152 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 153 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
7.6 OTHER APPLICATIONS
・ TABLE 154 CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 155 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 156 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 157 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 158 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8 CELL CULTURE MEDIA MARKET, BY END USER
8.1 INTRODUCTION
・ TABLE 159 CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 INCREASING RESEARCH EXPENDITURE BY PHARMA AND BIOTECH COMPANIES TO DRIVE MARKET
・ TABLE 160 PHARMA & BIOTECH SECTOR: RECENT DEVELOPMENTS
・ TABLE 161 CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 162 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 163 EUROPE: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 164 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 165 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 HOSPITALS & DIAGNOSTIC LABORATORIES
8.3.1 INCREASING APPLICATIONS OF CELL CULTURE MEDIA IN DISEASE DIAGNOSIS TO BOOST MARKET
・ TABLE 166 CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 167 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 168 EUROPE: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 169 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 170 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 RESEARCH & ACADEMIC INSTITUTES
8.4.1 GROWING PREVALENCE OF CANCER AND INCREASING RESEARCH FUNDING TO PROPEL MARKET
・ TABLE 171 CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 160
・ TABLE 172 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 173 EUROPE: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 174 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 175 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 OTHER END USERS
・ TABLE 176 CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 177 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 178 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 179 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 180 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
9 CELL CULTURE MEDIA MARKET, BY REGION
9.1 INTRODUCTION
・ TABLE 181 CELL CULTURE MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 RECESSION IMPACT 168
・ FIGURE 28 NORTH AMERICA: CELL CULTURE MEDIA MARKET SNAPSHOT
・ TABLE 182 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 183 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 184 NORTH AMERICA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 185 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 186 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 187 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 188 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.2 US
9.2.2.1 GROWING PHARMACEUTICAL AND BIOTECHNOLOGY SECTOR TO DRIVE MARKET 173
・ TABLE 189 US: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 190 US: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 191 US: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 192 US: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 193 US: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 194 US: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 INCREASE IN STEM CELL RESEARCH FUNDING IN CANADA TO FUEL MARKET GROWTH
・ TABLE 195 CANADA: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 196 CANADA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 197 CANADA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 198 CANADA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 199 CANADA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 200 CANADA: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3 EUROPE
9.3.1 RECESSION IMPACT 180
・ TABLE 201 EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 202 EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 203 EUROPE: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 204 EUROPE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 205 EUROPE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 206 EUROPE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 207 EUROPE: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 STRONG GROWTH IN BIOTECHNOLOGY INDUSTRY IN GERMANY TO DRIVE MARKET GROWTH
・ TABLE 208 GERMANY: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 209 GERMANY: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 210 GERMANY: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 211 GERMANY: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 212 GERMANY: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 213 GERMANY: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 UK
9.3.3.1 ADVANCEMENTS IN LIFE SCIENCES SECTOR TO BOOST MARKET
・ TABLE 214 UK: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 215 UK: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 216 UK: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 217 UK: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 218 UK: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 219 UK: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 FRANCE
9.3.4.1 INCREASE IN GOVERNMENT FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET
・ TABLE 220 FRANCE: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 221 FRANCE: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 222 FRANCE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 223 FRANCE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 224 FRANCE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 225 FRANCE: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.5 ITALY
9.3.5.1 GROWING SUPPORT FOR LIFE SCIENCE RESEARCH IN ITALY TO FUEL MARKET GROWTH
・ TABLE 226 ITALY: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 227 ITALY: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 228 ITALY: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 229 ITALY: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 230 ITALY: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 231 ITALY: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 ADVANCEMENT OF TRANSLATIONAL PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH IN SPAIN
・ TABLE 232 SPAIN: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 233 SPAIN: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 234 SPAIN: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 235 SPAIN: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 236 SPAIN: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 237 SPAIN: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.7 REST OF EUROPE
・ TABLE 238 REST OF EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 239 REST OF EUROPE: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 240 REST OF EUROPE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 241 REST OF EUROPE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 242 REST OF EUROPE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 243 REST OF EUROPE: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 RECESSION IMPACT 202
・ FIGURE 29 ASIA PACIFIC: CELL CULTURE MEDIA MARKET SNAPSHOT
・ TABLE 244 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 245 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 246 ASIA PACIFIC: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 247 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 248 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 249 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 250 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 INCREASING DEMAND FOR MONOCLONAL ANTIBODIES TO PROPEL MARKET
・ TABLE 251 CHINA: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 252 CHINA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 253 CHINA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 254 CHINA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 255 CHINA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 256 CHINA: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 JAPAN
9.4.3.1 STRATEGIC DEVELOPMENTS BY COMPANIES TO CONTRIBUTE TO MARKET GROWTH 210
・ TABLE 257 JAPAN: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 258 JAPAN: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 259 JAPAN: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 260 JAPAN: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 261 JAPAN: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 262 JAPAN: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 FAVORABLE GOVERNMENT REGULATIONS AND SUPPORT TO AUGMENT MARKET GROWTH
・ TABLE 263 INDIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 264 INDIA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 265 INDIA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 266 INDIA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 267 INDIA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 268 INDIA: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.5 SOUTH KOREA
9.4.5.1 INCREASING PHARMACEUTICAL AND BIOTECH R&D INVESTMENT TO BOLSTER MARKET
・ TABLE 269 SOUTH KOREA: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 270 SOUTH KOREA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 271 SOUTH KOREA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 272 SOUTH KOREA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 273 SOUTH KOREA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 274 SOUTH KOREA: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.6 REST OF ASIA PACIFIC
・ TABLE 275 REST OF ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 276 REST OF ASIA PACIFIC: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 277 REST OF ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 278 REST OF ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 279 REST OF ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 280 REST OF ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 RECESSION IMPACT 223
・ TABLE 281 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 282 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 283 LATIN AMERICA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 284 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 285 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 286 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 287 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.2 BRAZIL
9.5.2.1 EXPANDING PHARMACEUTICAL MARKET IN BRAZIL TO BOOST MARKET
・ TABLE 288 BRAZIL: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 289 BRAZIL: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 290 BRAZIL: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 291 BRAZIL: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 292 BRAZIL: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 293 BRAZIL: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.3 MEXICO
9.5.3.1 GROWTH IN PHARMACEUTICAL MARKET TO SPUR CELL CULTURE IN MEXICO
・ TABLE 294 MEXICO: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 295 MEXICO: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 296 MEXICO: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 297 MEXICO: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 298 MEXICO: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 299 MEXICO: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.4 REST OF LATIN AMERICA
・ TABLE 300 REST OF LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 301 REST OF LATIN AMERICA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 302 REST OF LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 303 REST OF LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 304 REST OF LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 305 REST OF LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 GROWING FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS TO PROPEL MARKET
9.6.2 RECESSION IMPACT 236
・ TABLE 306 MIDDLE EAST & AFRICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 307 MIDDLE EAST & AFRICA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 308 MIDDLE EAST AND AFRICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 309 MIDDLE EAST & AFRICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 310 MIDDLE EAST & AFRICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 311 MIDDLE EAST & AFRICA: CELL CULTURE MEDIA MARKET, BY END USER, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
・ FIGURE 30 CELL CULTURE MEDIA MARKET: STRATEGIES ADOPTED
10.3 MARKET SHARE ANALYSIS
・ FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
・ TABLE 312 CELL CULTURE MEDIA MARKET: DEGREE OF COMPETITION
10.4 REVENUE SHARE ANALYSIS
・ FIGURE 32 REVENUE ANALYSIS OF KEY PLAYERS (2019–2022)
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
・ FIGURE 33 CELL CULTURE MEDIA MARKET: COMPANY EVALUATION MATRIX, 2022
10.6 COMPETITIVE BENCHMARKING OF TOP 26 PLAYERS
10.6.1 PRODUCT FOOTPRINT OF COMPANIES (26 COMPANIES)
・ TABLE 313 CELL CULTURE MEDIA MARKET: PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
10.6.2 REGIONAL FOOTPRINT OF COMPANIES (26 COMPANIES)
・ TABLE 314 CELL CULTURE MEDIA MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
10.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES
10.7.1 PROGRESSIVE COMPANIES
10.7.2 RESPONSIVE COMPANIES
10.7.3 DYNAMIC COMPANIES
10.7.4 STARTING BLOCKS
・ FIGURE 34 CELL CULTURE MEDIA MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
10.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
・ TABLE 315 CELL CULTURE MEDIA MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
・ TABLE 316 CELL CULTURE MEDIA MARKET: COMPANY EVALUATION QUADRANT OF START-UP/SME PLAYERS
10.9 COMPETITIVE SCENARIO AND TRENDS
10.9.1 PRODUCT LAUNCHES 253
・ TABLE 317 CELL CULTURE MEDIA MARKET: PRODUCT LAUNCHES, JANUARY 2020–JUNE 2023
10.9.2 DEALS
・ TABLE 318 CELL CULTURE MEDIA MARKET: DEALS, JANUARY 2020 TO JUNE 2023
10.9.3 OTHER DEVELOPMENTS
・ TABLE 319 CELL CULTURE MEDIA MARKET: OTHER DEVELOPMENTS, JANUARY 2020 TO JUNE 2023
11 COMPANY PROFILES
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS & MNM VIEW)*
11.1 KEY PLAYERS 256
11.1.1 THERMO FISHER SCIENTIFIC INC.
・ TABLE 320 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
・ FIGURE 35 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
・ TABLE 321 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES
・ TABLE 322 THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS
11.1.2 MERCK KGAA
・ TABLE 323 MERCK KGAA: COMPANY OVERVIEW
・ FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT (2022)
・ TABLE 324 MERCK KGAA: DEALS
11.1.3 DANAHER
・ TABLE 325 DANAHER: COMPANY OVERVIEW
・ FIGURE 37 DANAHER: COMPANY SNAPSHOT (2022)
・ TABLE 326 DANAHER: DEALS
・ TABLE 327 DANAHER: OTHER DEVELOPMENTS 269
11.1.4 SARTORIUS AG
・ TABLE 328 SARTORIUS AG: BUSINESS OVERVIEW
・ FIGURE 38 SARTORIUS AG: COMPANY SNAPSHOT (2022)
・ TABLE 329 SARTORIUS AG: PRODUCT LAUNCHES 273
・ TABLE 330 SARTORIUS AG: DEALS
・ TABLE 331 SARTORIUS AG: OTHER DEVELOPMENTS
11.1.5 CORNING INCORPORATED
・ TABLE 332 CORNING INCORPORATED: BUSINESS OVERVIEW
・ FIGURE 39 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
11.1.6 FUJIFILM HOLDINGS CORPORATION
・ TABLE 333 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
・ FIGURE 40 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022)
・ TABLE 334 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES
・ TABLE 335 FUJIFILM HOLDINGS CORPORATION: DEALS
・ TABLE 336 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS
11.1.7 LONZA
・ TABLE 337 LONZA: BUSINESS OVERVIEW
・ FIGURE 41 LONZA: COMPANY SNAPSHOT (2022)
・ TABLE 338 LONZA: PRODUCT LAUNCHES
・ TABLE 339 LONZA: OTHER DEVELOPMENTS
11.1.8 BECTON, DICKINSON AND COMPANY (BD)
・ TABLE 340 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
・ FIGURE 42 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
11.1.9 STEMCELL TECHNOLOGIES
・ TABLE 341 STEMCELL TECHNOLOGIES: BUSINESS OVERVIEW
・ TABLE 342 STEMCELL TECHNOLOGIES: DEALS 289
11.1.10 MILTENYI BIOTEC
・ TABLE 343 MILTENYI BIOTEC: BUSINESS OVERVIEW
11.1.11 HIMEDIA LABORATORIES
・ TABLE 344 HIMEDIA LABORATORIES: BUSINESS OVERVIEW
11.1.12 BIOLOGOS
・ TABLE 345 BIOLOGOS: BUSINESS OVERVIEW 293
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS & MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
11.2 OTHER PLAYERS
11.2.1 CELL APPLICATIONS, INC.
・ TABLE 346 CELL APPLICATIONS, INC.: COMPANY OVERVIEW
11.2.2 CAISSON LABS INC. 295
・ TABLE 347 CAISSON LABS INC.: COMPANY OVERVIEW
11.2.3 PROMOCELL GMBH
・ TABLE 348 PROMOCELL GMBH: COMPANY OVERVIEW
11.2.4 CELL BIOLOGICS, INC.
・ TABLE 349 CELL BIOLOGICS, INC.: COMPANY OVERVIEW
11.2.5 INVIVOGEN
・ TABLE 350 INVIVOGEN: COMPANY OVERVIEW 298
11.2.6 PAN-BIOTECH
・ TABLE 351 PAN-BIOTECH: COMPANY OVERVIEW
11.2.7 CELLULAR TECHNOLOGY LIMITED
・ TABLE 352 CELLULAR TECHNOLOGY LIMITED: COMPANY OVERVIEW
11.2.8 ZENBIO, INC.
・ TABLE 353 ZENBIO, INC.: COMPANY OVERVIEW
11.2.9 ATHENA ENVIRONMENTAL SCIENCES, INC.
・ TABLE 354 ATHENA ENVIRONMENTAL SCIENCES, INC.: COMPANY OVERVIEW
11.2.10 CYAGEN BIOSCIENCES
・ TABLE 355 CYAGEN BIOSCIENCES: COMPANY OVERVIEW
11.2.11 BIOWEST
・ TABLE 356 BIOWEST: COMPANY OVERVIEW
11.2.12 AKRON BIOTECH
・ TABLE 357 AKRON BIOTECH.: COMPANY OVERVIEW
11.2.13 KCELL BIOSCIENCES
・ TABLE 358 KCELL BIOSCIENCES: COMPANY OVERVIEW
11.2.14 WELGENE INC.
・ TABLE 359 WELGENE INC.: COMPANY OVERVIEW